Amy Abernethy

Amy Abernethy, MD, PhD is the President of Clinical Studies Platforms at Alphabet’s Verily, where she has responsibility for the company’s Baseline program and other initiatives to support clinical trials and real-world evidence (RWE) studies. Before joining Verily, Dr. Abernethy was Principal Deputy Commissioner and Acting Chief Information Officer of the US Food & Drug …